Clinical implications and molecular mechanism of long noncoding RNA LINC00518 and protein-coding genes in skin cutaneous melanoma by genome‑wide investigation

  • 0Department of Respiratory, The First Affiliated Hospital of Guangxi Medical University, No. 6 Shuangyong Road, Nanning, Guangxi, 530000, People's Republic of China.

|

|

Summary

This summary is machine-generated.

This study identifies LINC00518 as a potential biomarker for skin cutaneous melanoma (SKCM). Its upregulation correlates with poor prognosis, while specific genes like TRAK2, EPM2A, and MITF show diagnostic value.

Area Of Science

  • Oncology
  • Genetics
  • Bioinformatics

Background

  • Skin cutaneous melanoma (SKCM) presents a significant global health challenge.
  • Long non-coding RNAs (lncRNAs) are increasingly recognized for their role in tumor prognosis.
  • Long intergenic non-protein coding (LINC) RNAs, specifically LINC00518, warrant investigation for their potential in SKCM.

Purpose Of The Study

  • To investigate the diagnostic and prognostic value of LINC00518 and its correlated protein-coding genes (PCGs) in SKCM.
  • To explore the molecular mechanisms and potential therapeutic targets associated with LINC00518 in SKCM.

Main Methods

  • Utilized gene expression data from The Cancer Genome Atlas (TCGA) and Oncomine, analyzing 458 SKCM cases.
  • Performed bioinformatic analyses to identify LINC00518 and 10 highly correlated PCGs for diagnostic and prognostic assessment.
  • Employed the Connectivity Map for pharmacological target prediction and drug selection.

Main Results

  • LINC00518, RASSF3, CABLES1, KAZN, EFCAB5, and MITF were significantly associated with SKCM prognosis (adjusted P < 0.05).
  • TRAK2, EPM2A, and MITF demonstrated significant diagnostic value (AUC > 0.7, P < 0.05).
  • LINC00518 was implicated in cell cycle, melanogenesis, MAPK signaling, cell division, and DNA repair pathways.

Conclusions

  • LINC00518 upregulation is linked to a poorer prognosis in SKCM.
  • TRAK2, EPM2A, MITF, RASSF3, CABLES1, KAZN, and EFCAB5 represent potential novel diagnostic and prognostic biomarkers for SKCM.
  • Identified eight potential therapeutic drugs targeting LINC00518 and associated genes.

Related Concept Videos

lncRNA - Long Non-coding RNAs 02:39

8.5K

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...

Non-LTR Retrotransposons 03:18

11.3K

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...

Loss of Tumor Suppressor Gene Functions 01:12

4.7K

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

MicroRNAs 01:22

3.0K

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...